Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
Clinical trial NCT00034307 · UNKNOWN
Trial details
- NCT number
- NCT00034307
- Sponsor
- ICOS-Texas Biotechnology
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.